Clinical trial

ORBERA™ Post-Approval Study

NCT02828657

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-06-01

PhaseN/A

Study timeline

Study start (actual)2016-06-01Date precision: month

Registry last updated2020-07-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Overweightunresolved

Interventions

Sponsors & collaborators

Apollo Endosurgery, Inc.lead sponsor

Mapped research locations

BaltimoreMaryland, United States1 CincinnatiOhio, United States1 San DiegoCalifornia, United States1 LouisvilleKentucky, United States1 Little RockArkansas, United States1 Baton RougeLouisiana, United States1 St. PetersburgFlorida, United States1 MetairieLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02828657 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.